These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21907174)

  • 21. Cardiac resynchronization therapy: antiarrhythmic or proarrhythmic?
    Curtis AB
    J Am Coll Cardiol; 2011 Jun; 57(24):2424-5. PubMed ID: 21658563
    [No Abstract]   [Full Text] [Related]  

  • 22. New technologies of internal defibrillation.
    Dosdall DJ; Ideker RE
    J Interv Card Electrophysiol; 2005 Aug; 13 Suppl 1():67-70. PubMed ID: 16133858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT.
    Doyle CL; Huang DT; Moss AJ; Solomon SD; Campbell P; McNitt S; Polonsky S; Barsheshet A; Aktas M; Tompkins C; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Oct; 10(10):1471-7. PubMed ID: 23872690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implantable Cardioverter Defibrillator Programming Characteristics, Shocked Rhythms, and Survival Among Patients Under Thirty Years of Age.
    Chang PM; Powell BD; Jones PW; Carter N; Hayes DL; Saxon LA
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1183-1190. PubMed ID: 27334356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Continued Cardiac Resynchronization Therapy on Ventricular Arrhythmias After Left Ventricular Assist Device Implantation.
    Schleifer JW; Mookadam F; Kransdorf EP; Nanda U; Adams JC; Cha S; Pajaro OE; Steidley DE; Scott RL; Carvajal T; Saadiq RA; Srivathsan K
    Am J Cardiol; 2016 Aug; 118(4):556-9. PubMed ID: 27328958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.
    Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.
    van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post automatic implantable cardioverter defibrillator implant therapies: drugs and ablative techniques.
    Colella A; Pieragnoli P; Ricciardi G; Giaccardi M; Padeletti L; Michelucci A
    Minerva Cardioangiol; 2007 Jun; 55(3):341-51. PubMed ID: 17534253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Statins on First and Recurrent Supraventricular Arrhythmias in Patients With Mild Heart Failure (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Biton Y; Goldenberg I; Kutyifa V; Zareba W; Szepietowska B; Mcnitt S; Polonsky B; Barsheshet A; Moss AJ
    Am J Cardiol; 2015 Dec; 116(12):1869-74. PubMed ID: 26508711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy.
    Ruwald MH; Mittal S; Ruwald AC; Aktas MK; Daubert JP; McNitt S; Al-Ahmad A; Jons C; Kutyifa V; Steinberg JS; Wang P; Moss AJ; Zareba W
    J Am Coll Cardiol; 2014 Sep; 64(10):971-81. PubMed ID: 25190230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Device therapy for acute systolic heart failure and atrial fibrillation.
    Carlson SK; Doshi RN
    Card Electrophysiol Clin; 2015 Sep; 7(3):469-77. PubMed ID: 26304527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between patient activity and long-term cardiac death in patients with implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators.
    Zhao S; Chen K; Su Y; Hua W; Chen S; Liang Z; Xu W; Dai Y; Liu Z; Fan X; Hou C; Zhang S
    Eur J Prev Cardiol; 2017 May; 24(7):760-767. PubMed ID: 28117620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.
    Lunati M; Proclemer A; Boriani G; Landolina M; Locati E; Rordorf R; Daleffe E; Ricci RP; Catanzariti D; Tomasi L; Gulizia M; Baccillieri MS; Molon G; Gasparini M;
    Europace; 2016 Sep; 18(9):1391-8. PubMed ID: 26826135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between left ventricular ejection fraction post-cardiac resynchronization treatment and subsequent implantable cardioverter defibrillator therapy for sustained ventricular tachyarrhythmias.
    Manfredi JA; Al-Khatib SM; Shaw LK; Thomas L; Fogel RI; Padanilam B; Rardon D; Vatthyam R; Gemma LW; Golden K; Prystowsky EN
    Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):257-64. PubMed ID: 23443618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies].
    Anadolu Kardiyol Derg; 2001 Mar; 1(1):43-7, AXIV. PubMed ID: 12132492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive hemodynamic and clinical response to tri-left ventricular pacing in a nonresponder to traditional cardiac resynchronization therapy.
    Ploux S; Barandon L; Ritter P; Bordachar P
    Heart Rhythm; 2011 Feb; 8(2):315-7. PubMed ID: 20950714
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy).
    Ruwald MH; Abu-Zeitone A; Jons C; Ruwald AC; McNitt S; Kutyifa V; Zareba W; Moss AJ
    J Am Coll Cardiol; 2013 Oct; 62(15):1343-50. PubMed ID: 23770172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction in life-threatening ventricular tachyarrhythmias in statin-treated patients with nonischemic cardiomyopathy enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy).
    Buber J; Goldenberg I; Moss AJ; Wang PJ; McNitt S; Hall WJ; Eldar M; Barsheshet A; Shechter M
    J Am Coll Cardiol; 2012 Aug; 60(8):749-55. PubMed ID: 22703927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Future of implantable devices for cardiac rhythm management.
    Lau CP; Siu CW; Tse HF
    Circulation; 2014 Feb; 129(7):811-22. PubMed ID: 24550552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.